Author: Vigilare Biopharma

  • Home
  • Vigilare Biopharma

Top 10 trends in pharmaceutical industry innovations to embrace in 2024

Here are the top 10 trends in pharmaceutical industry innovations to embrace in 2024 1. Rise in Pharmacovigilance Market: The pharmacovigilance market is expected to grow at a CAGR of 13.6% from 2021 to 2028.

Read More
Good Pharmacovigilance Practices by EU

Understanding Good Pharmacovigilance Practices (GVP): Ensuring the Safe Use of Medications

At Vigilare Biopharma We strongly believe that medications play a crucial role in modern healthcare, but their benefits are intricately linked to their safety. A robust pharmacovigilance system is vital to ensure that medications are

Read More

RFDA Registration & Listing of Cosmetic Product Facilities and Products

The cosmetic facility that manufactures or processes a cosmetic product for distribution in the United States on December 29, 2022, must register each facility before July 1, 2024. Cosmetic facilities that first engage in the

Read More
Biologics: Transforming Cancer Treatment for Improved Safety and Efficacy

Biologics: Transforming Cancer Treatment for Improved Safety and Efficacy

Biologics have transformed the landscape of cancer treatment, offering targeted and safer therapeutic options. These drugs are engineered to interfere with specific molecules or pathways involved in cancer growth, typically derived from living organisms or

Read More
The Safety Specification ICH e2e Guidelines

Scope of The Safety Specification ICH E2E guideline in Pharmacovigilance practice

Pharmacovigilance is the science and practice of monitoring, evaluating, and managing the safety of medicinal products. It is essential to ensure that the benefits of a product outweigh its risks, and to identify and prevent

Read More
Regulatory News

Pharma and Regulatory News Sep 22

New ZLG Document on Transport Verification Published At the end of August, the German Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz

Read More

Case Study of a manufacturer focused on Branded Formulations, Specialty Generic Injectables, Synthetic Biology, Vaccines and Biologics

Case Study An India based manufacturer, focused on Branded Formulations, Specialty Generic Injectables, Synthetic Biology, Vaccines and Biologics At A Glance Challenges Medical Inquiries Product Complaints Adverse Drug Experience Reporting Other Categories Combination of the

Read More

Adverse Drug Reactions Reported Each Year On Rise

ADRs refer to harmful or unintended reactions caused by the use of medications or medical treatments. They range from mild side effects to severe and life-threatening events

Read More